Glycated Albumin Promotes a Generalized Vasculopathy in the db/db Mouse

Authors: Cohen M.P.^{1, 2}; Clements R.S.^{1, 2}; Cohen J.A.^{1, 2}; Shearman C.W.^{1, 2}

Source: Biochemical and Biophysical Research Communications, Volume 218, Number 1, January 1996 , pp. 72-75(4)

Buy & download fulltext article:

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

Increased protein glycation has been mechanistically linked to accelerated vascular pathobiology in diabetes. Because glycated albumin induces biosynthetic abnormalities in cultured aortic endothelial cells that resemble those associated with macrovascular disease, we sought evidence that increased glycated albumin is operative in the genesis of diabetic vasculopathy in vivo . Plasma concentrations of fibronectin, a sensitive marker of endothelial cell damage, were increased two-fold in diabetic db/db mice compared with their nondiabetic db/m littermates. Treatment with monoclonal antibodies specifically reactive with albumin modified by Amadori glucose adducts normalized fibronectin in diabetic animals despite persistent hyperglycemia. These findings suggest that increased glycated albumin causally contributes to diabetic vasculopathy, and that blocking this influence ameliorates vascular damage.

Language: English

Document Type: Research article

Affiliations: 1: Department of Medicine and Biochemistry, University of Pennsylvania, Philadelphia, PA, 19104 2: Exocell, Inc., 3508 Market Street, Philadelphia, PA, 19104

Publication date: 1996-01-01